Medical
National consultation to set MRFF medical research priorities
![Medical Pharma Biotech MedTech - National consultation to set MRFF medical research priorities](https://www.healthindustryhub.com.au/wp-content/uploads/2020/09/Greg-Hunt.jpg)
Medical News: A national consultation process will guide the third set of the Morrison Government’s ground-breaking Medical Research Future Fund (MRFF) Australian Medical Research and Innovation Priorities for 2020–2022.
This consultation process will ensure the MRFF continues to target national health priorities for better health outcomes.
Nadia Levin, CEO and Managing Director said “With the MRFF reaching full capitalisation of $20 billion this year, it plays as key funding role for all stages of Australian health and medical research. As we have throughout the history of MRFF, Research Australia will be engaging closely in the development of the next set of priorities to ensure that all stages of the medical research pipeline can benefit. It will be central to growing our sector and positioning Australia as a global leader in health and medical research and innovation.”
Determining future health priorities is about taking into account the burden of disease in Australians and the need to enhance the translation of research into clinical practice.
Australia’s health and medical researchers are world class and the Government continues to drive investment in ways that deliver the practical benefits of medical research and innovation to all Australians.
The landmark $20 billion MRFF is enhancing this growth in Australia’s cutting-edge health and medical research.
It is leading to new cures and treatments across Australia—saving lives and improving lives. The Australian public, organisations with expertise in health and medical research and innovation, consumer representatives, clinicians and health services managers are invited to contribute to the consultation.
Consultation is now open to inform the development of the Medical Research Future Fund (MRFF) Australian Medical Research and Innovation Priorities for 2020–22.
The Australian Medical Research Advisory Board is seeking comment from interested parties through online submissions and public webinars until 7 October 2020.
Visit the Department of Health’s Consultation Hub to see how you can comment online.
News & Trends - Biotechnology
![Aussie biotech secures agreement with UQ and USyd to advance cardiovascular diseases research](https://www.healthindustryhub.com.au/wp-content/uploads/2024/07/Aussie-biotech-secures-agreement-with-UQ-and-USyd-to-advance-cardiovascular-diseases-research.png)
Aussie biotech secures agreement with UQ and USyd to advance cardiovascular diseases research
Biotech News: Australian biotechnology company, Cartherics, developing immune cell therapies for the treatment of cancer, has entered into a Technology […]
MoreNews & Trends - MedTech & Diagnostics
![NSW Health Secretary urges more focus on patient experience, drawing from her own heart valve disease journey](https://www.healthindustryhub.com.au/wp-content/uploads/2024/07/NSW-Health-Secretary-urges-more-focus-on-patient-experience-drawing-from-her-own-heart-valve-disease-journey.png)
NSW Health Secretary urges more focus on patient experience, drawing from her own heart valve disease journey
In a heart-warming event that united patients, their loved ones, representatives from patient organisations and employees, Edwards Lifesciences hosted its […]
MoreHuman Resources
!['To be an inclusive society, we need an embedded national strategy to combat systemic racism', says Commissioner Sivaraman](https://www.healthindustryhub.com.au/wp-content/uploads/2024/07/To-be-an-inclusive-society-we-need-an-embedded-national-strategy-to-combat-systemic-racism-says-Commissioner-Sivaraman.png)
‘To be an inclusive society, we need an embedded national strategy to combat systemic racism’, says Commissioner Sivaraman
Race Discrimination Commissioner Giridharan Sivaraman has welcomed the release of the Multicultural Framework Review by the Federal Government, calling it […]
MoreNews & Trends - Pharmaceuticals
![New shingles vaccine is linked with lower risk of dementia](https://www.healthindustryhub.com.au/wp-content/uploads/2024/07/New-shingles-vaccine-is-linked-with-lower-risk-of-dementia.png)
Shingles vaccine lowers risk of dementia
Pharma News: A recombinant shingles vaccine which was added to Australia’s National Immunisation Program (NIP) in November last year, is […]
More